-
1
-
-
0030326445
-
Definition and pathogenesis of septic shock
-
Vincent JL: Definition and pathogenesis of septic shock. Curr Top Microbiol Immunol 1996;216:1-13.
-
(1996)
Curr Top Microbiol Immunol
, vol.216
, pp. 1-13
-
-
Vincent, J.L.1
-
2
-
-
0030324466
-
Significance and pathogenesis of septic shock
-
Brandtzaeg P: Significance and pathogenesis of septic shock. Curr Top Microbiol Immunol 1996;216:15-37.
-
(1996)
Curr Top Microbiol Immunol
, vol.216
, pp. 15-37
-
-
Brandtzaeg, P.1
-
3
-
-
0030322173
-
Bacterial endotoxin: Chemical constitution, biological recognition, host response, and immunological detoxification
-
Rietschel ET, Brade H, Holst O, Brade L, Müller-Loennies S, Mamat U, Zähringer U, Beckmann F, Seydel U, Brandenburg K, Ulmer AJ, Mattern T, Heine H, Schletter J, Loppnow H, Schönbeck U, Flad H-D, Hauschildt S, Schade UF, DiPadova F, Kusumoto S, Schumann RR: Bacterial endotoxin: Chemical constitution, biological recognition, host response, and immunological detoxification. Curr Top Microbiol Immunol 1996;216:39-81.
-
(1996)
Curr Top Microbiol Immunol
, vol.216
, pp. 39-81
-
-
Rietschel, E.T.1
Brade, H.2
Holst, O.3
Brade, L.4
Müller-Loennies, S.5
Mamat, U.6
Zähringer, U.7
Beckmann, F.8
Seydel, U.9
Brandenburg, K.10
Ulmer, A.J.11
Mattern, T.12
Heine, H.13
Schletter, J.14
Loppnow, H.15
Schönbeck, U.16
Flad, H.-D.17
Hauschildt, S.18
Schade, U.F.19
DiPadova, F.20
Kusumoto, S.21
Schumann, R.R.22
more..
-
6
-
-
0022332798
-
Blood coagulation and fibrinolytic factors as well as their inhibitors in trauma
-
Blombäck M, Eklund J, Hellgren M, Lagerkranser M, Swedenbord J: Blood coagulation and fibrinolytic factors as well as their inhibitors in trauma. Scand J Clin Lab Invest 1985; 45(suppl 178):15-23.
-
(1985)
Scand J Clin Lab Invest
, vol.45
, Issue.SUPPL. 178
, pp. 15-23
-
-
Blombäck, M.1
Eklund, J.2
Hellgren, M.3
Lagerkranser, M.4
Swedenbord, J.5
-
7
-
-
0343284173
-
Diagnosis and management of bleeding disorders
-
Ayres SM (ed): London, Saunders
-
Bang NU: Diagnosis and management of bleeding disorders; in Ayres SM (ed): Textbook of Critical Care, ed 3. London, Saunders, 1995, pp 1324-1334.
-
(1995)
Textbook of Critical Care, Ed 3
, pp. 1324-1334
-
-
Bang, N.U.1
-
8
-
-
0026696703
-
Complement activation and the production of inflammatory mediators during the treatment of severe sepsis in humans
-
Dofferhoff AS, de Jong HJ, Bom VJ, van der Meer J, Limburg PC, de Vries Hospers HG, Marrink J, Mulder PO, Weits J: Complement activation and the production of inflammatory mediators during the treatment of severe sepsis in humans. Scand J Infect Dis 1992;24:197-204.
-
(1992)
Scand J Infect Dis
, vol.24
, pp. 197-204
-
-
Dofferhoff, A.S.1
De Jong, H.J.2
Bom, V.J.3
Van Der Meer, J.4
Limburg, P.C.5
De Vries Hospers, H.G.6
Marrink, J.7
Mulder, P.O.8
Weits, J.9
-
9
-
-
0029903114
-
Sir Isaac Newton, sepsis, SIRS, and CARS
-
Bone RC: Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 1996;24:1125-1128.
-
(1996)
Crit Care Med
, vol.24
, pp. 1125-1128
-
-
Bone, R.C.1
-
10
-
-
0030587937
-
Immunologic dissonance: A continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS)
-
Bone RC: Immunologic dissonance: A continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann Intern Med 1996;125:680-687.
-
(1996)
Ann Intern Med
, vol.125
, pp. 680-687
-
-
Bone, R.C.1
-
11
-
-
0026632551
-
Superantigens, T cells, and microbes
-
Zumla A: Superantigens, T cells, and microbes. Clin Infect Dis 1992;15:313-320.
-
(1992)
Clin Infect Dis
, vol.15
, pp. 313-320
-
-
Zumla, A.1
-
12
-
-
0029835023
-
INTERSEPT: An international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis
-
International Sepsis Trial Study Group.
-
Cohen J, Carlet J: INTERSEPT: An international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group. Crit Care Med 1996;24:1431-1440.
-
(1996)
Crit Care Med
, vol.24
, pp. 1431-1440
-
-
Cohen, J.1
Carlet, J.2
-
13
-
-
23444446083
-
Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis
-
Natanson C, Hoffman WD, Suffredini AF, Eichacker PQ, Danner RL: Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med 1994;120:771-783.
-
(1994)
Ann Intern Med
, vol.120
, pp. 771-783
-
-
Natanson, C.1
Hoffman, W.D.2
Suffredini, A.F.3
Eichacker, P.Q.4
Danner, R.L.5
-
14
-
-
9344246862
-
Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: A multicenter, randomised, placebo-controlled, dose-ranging study
-
Reinhart K, Wiegand LC, Grimminger F, Kaul M, Withington S, Treacher D, Eckart J, Willatts S, Bouza C, Krausch D, Stockenhuber F, Eiselstein J, Daum L, Kempeni J: Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: A multicenter, randomised, placebo-controlled, dose-ranging study. Crit Care Med 1996;24:733-742.
-
(1996)
Crit Care Med
, vol.24
, pp. 733-742
-
-
Reinhart, K.1
Wiegand, L.C.2
Grimminger, F.3
Kaul, M.4
Withington, S.5
Treacher, D.6
Eckart, J.7
Willatts, S.8
Bouza, C.9
Krausch, D.10
Stockenhuber, F.11
Eiselstein, J.12
Daum, L.13
Kempeni, J.14
-
15
-
-
0029900294
-
Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein
-
The Soluble TNF Receptor Sepsis Study Group.
-
Fisher CJ, Agosti JM, Opal SM, Lowry SF, Balk RA, Sadoff JC, Abraham E, Schein RM, Benjamin E. Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med 1996;334:1697-1702.
-
(1996)
N Engl J Med
, vol.334
, pp. 1697-1702
-
-
Fisher, C.J.1
Agosti, J.M.2
Opal, S.M.3
Lowry, S.F.4
Balk, R.A.5
Sadoff, J.C.6
Abraham, E.7
Schein, R.M.8
Benjamin, E.9
-
16
-
-
0028239555
-
Recombinant human interleukin I receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomised, double-blind, placebo-controlled trial
-
Phase III rhIL-lra Sepsis Syndrome Study Group.
-
Fisher CJ, Dhainaut JF, Opal SM, Pribble JP, Balk RA, Slotman GJ, Iberti TJ, Rackow EC, Shapiro MJ, Greenman RL, et al: Recombinant human interleukin I receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomised, double-blind, placebo-controlled trial. Phase III rhIL-lra Sepsis Syndrome Study Group. JAMA 1994;271:1836-1843.
-
(1994)
JAMA
, vol.271
, pp. 1836-1843
-
-
Fisher, C.J.1
Dhainaut, J.F.2
Opal, S.M.3
Pribble, J.P.4
Balk, R.A.5
Slotman, G.J.6
Iberti, T.J.7
Rackow, E.C.8
Shapiro, M.J.9
Greenman, R.L.10
-
17
-
-
9344240407
-
Use of predicted risk of mortality to evaluate the efficacy of anticytokine therapy in sepsis
-
The rhIL-lra Phase III Sepsis Syndrome Study Group.
-
Knaus WA, Harrell FJ, LaBrecque JF, Wagner DP, Pribble JP, Draper EA, Fisher CJ, Soll L: Use of predicted risk of mortality to evaluate the efficacy of anticytokine therapy in sepsis. The rhIL-lra Phase III Sepsis Syndrome Study Group. Crit Care Med 1996;24:46-56.
-
(1996)
Crit Care Med
, vol.24
, pp. 46-56
-
-
Knaus, W.A.1
Harrell, F.J.2
LaBrecque, J.F.3
Wagner, D.P.4
Pribble, J.P.5
Draper, E.A.6
Fisher, C.J.7
Soll, L.8
-
18
-
-
0032918108
-
Supplemental immune globulins in sepsis
-
Werdan K: Supplemental immune globulins in sepsis. Clin Chem Lab Med 1999;37:341-349.
-
(1999)
Clin Chem Lab Med
, vol.37
, pp. 341-349
-
-
Werdan, K.1
-
19
-
-
7144251856
-
Antithrombin III (AT III) replacement therapy in patients with sepsis and/or postsurgical complications: A controlled double-blind, randomised, multicenter study
-
Baudo F, Caimi TM, de CF, Ravizza A, Arlati S, Casella G, Carugo D, Palareti G, Legnani C, Ridolfi L, Rossi R, D'Angelo A, Crippa L, Giudici D, Gallioli G, Wolfler A, Calori G: Antithrombin III (AT III) replacement therapy in patients with sepsis and/or postsurgical complications: A controlled double-blind, randomised, multicenter study. Intens Care Med 1998; 24:336-342.
-
(1998)
Intens Care Med
, vol.24
, pp. 336-342
-
-
Baudo, F.1
Caimi, T.M.2
De, C.F.3
Ravizza, A.4
Arlati, S.5
Casella, G.6
Carugo, D.7
Palareti, G.8
Legnani, C.9
Ridolfi, L.10
Rossi, R.11
D'Angelo, A.12
Crippa, L.13
Giudici, D.14
Gallioli, G.15
Wolfler, A.16
Calori, G.17
-
20
-
-
0031962714
-
Effect of pentoxifylline in severe sepsis: Results of a randomised, double-blind, placebo-controlled study
-
Staubach KH, Schroder J, Stuber F, Gehrke K, Traumann E, Zabel P: Effect of pentoxifylline in severe sepsis: Results of a randomised, double-blind, placebo-controlled study. Arch Surg 1998;133:94-100.
-
(1998)
Arch Surg
, vol.133
, pp. 94-100
-
-
Staubach, K.H.1
Schroder, J.2
Stuber, F.3
Gehrke, K.4
Traumann, E.5
Zabel, P.6
-
21
-
-
0027499767
-
Detrimental effects of high-dose methylprednisolone sodium succinate on serum concentrations of hepatic and renal function indicators in severe sepsis and septic shock
-
The Methylprednisolone Severe Sepsis Study Group.
-
Slotman GJ, Fisher CJ, Bone RC, Clemmer TP, Metz CA: Detrimental effects of high-dose methylprednisolone sodium succinate on serum concentrations of hepatic and renal function indicators in severe sepsis and septic shock. The Methylprednisolone Severe Sepsis Study Group. Crit Care Med 1993;21:191-195.
-
(1993)
Crit Care Med
, vol.21
, pp. 191-195
-
-
Slotman, G.J.1
Fisher, C.J.2
Bone, R.C.3
Clemmer, T.P.4
Metz, C.A.5
-
22
-
-
0029090390
-
Corticosteroid treatment for sepsis: A critical appraisal and meta-analysis of the literature
-
Cronin L, Cook DJ, Carlet J, Heyland DK, King D, Lansang MA, Fisher CJ: Corticosteroid treatment for sepsis: A critical appraisal and meta-analysis of the literature. Crit Care Med 1995;23:14.30-1439.
-
(1995)
Crit Care Med
, vol.23
, pp. 1430-1439
-
-
Cronin, L.1
Cook, D.J.2
Carlet, J.3
Heyland, D.K.4
King, D.5
Lansang, M.A.6
Fisher, C.J.7
-
23
-
-
0031942028
-
Reversal of late septic shock with supraphysiologic doses of hydrocortisone
-
Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A: Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998;26:645-650.
-
(1998)
Crit Care Med
, vol.26
, pp. 645-650
-
-
Bollaert, P.E.1
Charpentier, C.2
Levy, B.3
Debouverie, M.4
Audibert, G.5
Larcan, A.6
-
24
-
-
0004976875
-
Analysis of efficiency of plasmapheresis in treatment of severe sepsis and septic shock: A prospective, randomised, clinical trial
-
Saarbrücken
-
Koukline V, Utrobin U, Busund R, Nedashkovsky E: Analysis of efficiency of plasmapheresis in treatment of severe sepsis and septic shock: A prospective, randomised, clinical trial (abstract). 2nd Int Congr Int Soc for Apheresis. Saarbrücken, 1999, p 109.
-
(1999)
2nd Int Congr Int Soc for Apheresis
, pp. 109
-
-
Koukline, V.1
Utrobin, U.2
Busund, R.3
Nedashkovsky, E.4
-
25
-
-
0024548110
-
Complement activation in plasma exchange by single filtration and centrifugation and in cascade filtration
-
Stegmayr B, Tärnvik A: Complement activation in plasma exchange by single filtration and centrifugation and in cascade filtration. Blood Purif 1989;7:10-15.
-
(1989)
Blood Purif
, vol.7
, pp. 10-15
-
-
Stegmayr, B.1
Tärnvik, A.2
-
26
-
-
0002176257
-
Permeation of complement factors through high-flux dialyzers and plasma separation membranes
-
Bambauer R, Malchesky PS, Falkenhagen D (eds): Stuttgart, Schattauer
-
Falkenhagen D, Brown GS, Boettcher M, Falkenhagen U, Schmidt B, Gurland HJ, Klinkmann H: Permeation of complement factors through high-flux dialyzers and plasma separation membranes; in Bambauer R, Malchesky PS, Falkenhagen D (eds): Therapeutic Plasma Exchange and Selective Plasma Separation. Stuttgart, Schattauer, 1987, pp 215-222.
-
(1987)
Therapeutic Plasma Exchange and Selective Plasma Separation
, pp. 215-222
-
-
Falkenhagen, D.1
Brown, G.S.2
Boettcher, M.3
Falkenhagen, U.4
Schmidt, B.5
Gurland, H.J.6
Klinkmann, H.7
-
27
-
-
0001881622
-
Long-term study of the protein profiles in healthy volunteers after plasma exchange
-
Bambauer R, Malchesky PS, Falkenhagen D (eds): Stuttgart, Schattauer
-
Kotitschke R, Borberg H, Güsken G: Long-term study of the protein profiles in healthy volunteers after plasma exchange; in Bambauer R, Malchesky PS, Falkenhagen D (eds): Therapeutic Plasma Exchange and Selective Plasma Separation. Stuttgart, Schattauer, 1987. pp 199-204.
-
(1987)
Therapeutic Plasma Exchange and Selective Plasma Separation
, pp. 199-204
-
-
Kotitschke, R.1
Borberg, H.2
Güsken, G.3
-
28
-
-
15644374485
-
Therapeutic apheresis for septic patients with organ dysfunction: Hemoperfusion using a polymyxin B immobilized column
-
Tani T, Hanasawa K, Endo Y, Yoshioka T, Kodama M, Kaneko M, Uchiyama Y, Akizawa T, Takahasi K, Sugai K: Therapeutic apheresis for septic patients with organ dysfunction: Hemoperfusion using a polymyxin B immobilized column. Artif Organs 1998;22:1038-1044.
-
(1998)
Artif Organs
, vol.22
, pp. 1038-1044
-
-
Tani, T.1
Hanasawa, K.2
Endo, Y.3
Yoshioka, T.4
Kodama, M.5
Kaneko, M.6
Uchiyama, Y.7
Akizawa, T.8
Takahasi, K.9
Sugai, K.10
-
29
-
-
0001407463
-
Correlation between plasma endotoxin, plasma cytokines and plasminogen activator inhibitor-1 activities in septic patients
-
Tani T, Hanasawa K, Kodama M, Imaizumi H, Yonekawa M, Saito M, Ikeda T, Yagi Y, Takayama K, Amano I, Shimaoka H, Ohta M, Katayama H, Okahisa T, Kato M, Koga N, Fujita N: Correlation between plasma endotoxin, plasma cytokines and plasminogen activator inhibitor-1 activities in septic patients (abstract). Ther Apher 1999;3:143.
-
(1999)
Ther Apher
, vol.3
, pp. 143
-
-
Tani, T.1
Hanasawa, K.2
Kodama, M.3
Imaizumi, H.4
Yonekawa, M.5
Saito, M.6
Ikeda, T.7
Yagi, Y.8
Takayama, K.9
Amano, I.10
Shimaoka, H.11
Ohta, M.12
Katayama, H.13
Okahisa, T.14
Kato, M.15
Koga, N.16
Fujita, N.17
-
30
-
-
0000748882
-
Effect of endotoxin adsorption with polymyxin B immobilized fibre on hemodynamics in severe sepsis
-
Kanesaka S, Ogata H, Akizawa T, Takahashi Y: Effect of endotoxin adsorption with polymyxin B immobilized fibre on hemodynamics in severe sepsis (abstract). Ther Apher 1999;3: 124.
-
(1999)
Ther Apher
, vol.3
, pp. 124
-
-
Kanesaka, S.1
Ogata, H.2
Akizawa, T.3
Takahashi, Y.4
-
31
-
-
0029793532
-
Bacteremia and severe sepsis in adults: A multicenter prospective survey in ICUs and wards of 24 hospitals
-
French Bacteremia-Sepsis Study Group.
-
Brun Buisson C, Doyon F, Carlet J: Bacteremia and severe sepsis in adults: A multicenter prospective survey in ICUs and wards of 24 hospitals. French Bacteremia-Sepsis Study Group. Am J Respir Crit Care Med 1996;154:617-624.
-
(1996)
Am J Respir Crit Care Med
, vol.154
, pp. 617-624
-
-
Brun Buisson, C.1
Doyon, F.2
Carlet, J.3
-
32
-
-
0030946482
-
Septic shock in bacteremic patients: Risk factors, features and prognosis
-
Leibovici L, Drucker M, Konigsberger H, Samra Z, Harrari S, Ashkenazi S, Pitlik SD: Septic shock in bacteremic patients: Risk factors, features and prognosis. Scand J Infect Dis 1997; 29:71-75.
-
(1997)
Scand J Infect Dis
, vol.29
, pp. 71-75
-
-
Leibovici, L.1
Drucker, M.2
Konigsberger, H.3
Samra, Z.4
Harrari, S.5
Ashkenazi, S.6
Pitlik, S.D.7
-
33
-
-
0029401567
-
The Italian SEPSIS study: Preliminary results on the incidence and evolution of SIRS, sepsis, severe sepsis and septic shock
-
Salvo I, de Cian W, Musicco M, Langer M, Piadena R, Wolfler A, Montani C, Magni E: The Italian SEPSIS study: Preliminary results on the incidence and evolution of SIRS, sepsis, severe sepsis and septic shock. Intens Care Med 1995;21(suppl):244-249.
-
(1995)
Intens Care Med
, vol.21
, Issue.SUPPL.
, pp. 244-249
-
-
Salvo, I.1
De Cian, W.2
Musicco, M.3
Langer, M.4
Piadena, R.5
Wolfler, A.6
Montani, C.7
Magni, E.8
-
34
-
-
0031934514
-
Renal involvement in the systemic inflammatory reaction syndrome
-
Karnik AM, Bashir R, Khan FA, Carvounis CP: Renal involvement in the systemic inflammatory reaction syndrome. Ren Fail 1998;20: 103-116.
-
(1998)
Ren Fail
, vol.20
, pp. 103-116
-
-
Karnik, A.M.1
Bashir, R.2
Khan, F.A.3
Carvounis, C.P.4
-
35
-
-
0032968238
-
Relationship of antibodies to endotoxin core to mortality in medical patients with sepsis syndrome
-
Strutz F, Heller G, Krasemann K, Krone B, Muller GA: Relationship of antibodies to endotoxin core to mortality in medical patients with sepsis syndrome. Intens Care Med 1999;25: 435-444.
-
(1999)
Intens Care Med
, vol.25
, pp. 435-444
-
-
Strutz, F.1
Heller, G.2
Krasemann, K.3
Krone, B.4
Muller, G.A.5
-
36
-
-
0031781591
-
Prediction of mortality in febrile medical patients: How useful are systemic inflammatory response syndrome and sepsis criteria?
-
Bossink AW, Groeneveld J, Hack CE, Thijs LG: Prediction of mortality in febrile medical patients: How useful are systemic inflammatory response syndrome and sepsis criteria? Chest 1998;113:1533-1541.
-
(1998)
Chest
, vol.113
, pp. 1533-1541
-
-
Bossink, A.W.1
Groeneveld, J.2
Hack, C.E.3
Thijs, L.G.4
-
37
-
-
2442753339
-
Time course and prognostic significance of hemostatic changes in sepsis: Relation to tumor necrosis factor-alpha
-
Martinez MA, Pena JM, Fernandez A, Jimenez M, Juarez S, Madero R, Vazquez JJ: Time course and prognostic significance of hemostatic changes in sepsis: Relation to tumor necrosis factor-alpha. Crit Care Med 1999;27:1303-1308.
-
(1999)
Crit Care Med
, vol.27
, pp. 1303-1308
-
-
Martinez, M.A.1
Pena, J.M.2
Fernandez, A.3
Jimenez, M.4
Juarez, S.5
Madero, R.6
Vazquez, J.J.7
-
38
-
-
0032495658
-
Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock
-
NORA-SEPT II Study Group.
-
Abraham E, Anzueto A, Gutienez G, Tessler S, San Pedro G, Wunderink R, Dal Nogare A, Nasraway S, Berman S, Cooney R, Levy H, Baughman R, Rumbak M, Light RB, Poole L, Allred R, Constant J, Pennington J, Porter S: Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORA-SEPT II Study Group. Lancet 1998;351:929-933.
-
(1998)
Lancet
, vol.351
, pp. 929-933
-
-
Abraham, E.1
Anzueto, A.2
Gutienez, G.3
Tessler, S.4
San Pedro, G.5
Wunderink, R.6
Dal Nogare, A.7
Nasraway, S.8
Berman, S.9
Cooney, R.10
Levy, H.11
Baughman, R.12
Rumbak, M.13
Light, R.B.14
Poole, L.15
Allred, R.16
Constant, J.17
Pennington, J.18
Porter, S.19
-
39
-
-
0031979528
-
Outcome of patients with sepsis and septic shock after ICU treatment
-
Schoenberg MH, Weiss M, Radermacher P: Outcome of patients with sepsis and septic shock after ICU treatment. Langenbecks Arch Surg 1998;383:44-48.
-
(1998)
Langenbecks Arch Surg
, vol.383
, pp. 44-48
-
-
Schoenberg, M.H.1
Weiss, M.2
Radermacher, P.3
-
40
-
-
0032725134
-
Persistent preload defect in severe sepsis despite fluid loading: A longitudinal cehocardiographic study in patients with septic shock
-
Jardin F, Fourme T, Page B, Loubieres Y, Vieillard-Baron A, Beauchet A, Bourdarias JP: Persistent preload defect in severe sepsis despite fluid loading: A longitudinal cehocardiographic study in patients with septic shock. Chest 1999;116:1354-1359.
-
(1999)
Chest
, vol.116
, pp. 1354-1359
-
-
Jardin, F.1
Fourme, T.2
Page, B.3
Loubieres, Y.4
Vieillard-Baron, A.5
Beauchet, A.6
Bourdarias, J.P.7
-
41
-
-
0030022536
-
Acute renal failure in intensive care units -causes, outcome, and prognostic factors of hospital mortality: A prospective, multicenter study
-
French Study Group on Acute Renal Failure
-
Brivet FG, Kleinknecht DJ, Lcirat P, Landais PJ: Acute renal failure in intensive care units -causes, outcome, and prognostic factors of hospital mortality: A prospective, multicenter study. French Study Group on Acute Renal Failure, Crit Care Med 1996;24:192-198.
-
(1996)
Crit Care Med
, vol.24
, pp. 192-198
-
-
Brivet, F.G.1
Kleinknecht, D.J.2
Lcirat, P.3
Landais, P.J.4
-
42
-
-
0030025549
-
Prognostic factors in acute renal failure due to sepsis. Results of a prospective multicentre study
-
The French Study Group on Acute Renal Failure.
-
Neveu H, Kleinknecht D, Brivet F, Loirat P, Landais P: Prognostic factors in acute renal failure due to sepsis. Results of a prospective multicentre study. The French Study Group on Acute Renal Failure. Nephrol Dial Transplant 1996;11:293-299.
-
(1996)
Nephrol Dial Transplant
, vol.11
, pp. 293-299
-
-
Neveu, H.1
Kleinknecht, D.2
Brivet, F.3
Loirat, P.4
Landais, P.5
-
43
-
-
0030938725
-
Acute renal failure: Clinical outcome and causes of death
-
Barretti P, Soares VA: Acute renal failure: Clinical outcome and causes of death. Ren Fail 1997;19:253-257.
-
(1997)
Ren Fail
, vol.19
, pp. 253-257
-
-
Barretti, P.1
Soares, V.A.2
-
44
-
-
0031901614
-
Predictors of mortality and the provision of dialysis in patients with acute tubular necrosis
-
The Auriculin Anaritide Acute Renal Failure Study Group.
-
Chertow GM, Lazarus JM, Paganini EP, Allgren RL, Lafayette RA, Sayegh MH: Predictors of mortality and the provision of dialysis in patients with acute tubular necrosis. The Auriculin Anaritide Acute Renal Failure Study Group. J Am Soc Nephrol 1998;9:692-698.
-
(1998)
J Am Soc Nephrol
, vol.9
, pp. 692-698
-
-
Chertow, G.M.1
Lazarus, J.M.2
Paganini, E.P.3
Allgren, R.L.4
Lafayette, R.A.5
Sayegh, M.H.6
-
45
-
-
0032705224
-
Influence of renal replacement therapy on outcome of patients with acute renal failure
-
Kresse S, Schlee H, Deuber HJ, Kohll W, Osten B: Influence of renal replacement therapy on outcome of patients with acute renal failure. Kidney Int Suppl 1999;72:75-78.
-
(1999)
Kidney Int Suppl
, vol.72
, pp. 75-78
-
-
Kresse, S.1
Schlee, H.2
Deuber, H.J.3
Kohll, W.4
Osten, B.5
-
46
-
-
0032979679
-
Prevalence and clinical outcome associated with preexisting malnutrition in acute renal failure: A prospective cohort study
-
Fiaccadori E, Lombardi M, Leonardi S, Rotelli CF, Tortorella G, Borghetti A: Prevalence and clinical outcome associated with preexisting malnutrition in acute renal failure: A prospective cohort study. J Am Soc Nephrol 1999;10: 581-593.
-
(1999)
J Am Soc Nephrol
, vol.10
, pp. 581-593
-
-
Fiaccadori, E.1
Lombardi, M.2
Leonardi, S.3
Rotelli, C.F.4
Tortorella, G.5
Borghetti, A.6
-
48
-
-
0027946293
-
Effect of the dialysis membrane in the treatment of patients with acute renal failure
-
Hakim RM, Wingard RL, Parker RA: Effect of the dialysis membrane in the treatment of patients with acute renal failure. N Engl J Med 1994;331:1338-1342.
-
(1994)
N Engl J Med
, vol.331
, pp. 1338-1342
-
-
Hakim, R.M.1
Wingard, R.L.2
Parker, R.A.3
-
49
-
-
0029011914
-
Prognostic stratification in critically ill patients with acute renal failure requiring dialysis
-
Chertow GM, Christiansen CL, Cleary PD, Munro C, Lazarus JM: Prognostic stratification in critically ill patients with acute renal failure requiring dialysis. Arch Intern Med 1995;155:1505-1511.
-
(1995)
Arch Intern Med
, vol.155
, pp. 1505-1511
-
-
Chertow, G.M.1
Christiansen, C.L.2
Cleary, P.D.3
Munro, C.4
Lazarus, J.M.5
-
50
-
-
0029931162
-
Survivors of acute renal failure who do not recover renal function
-
Bhandari S, Turney JH: Survivors of acute renal failure who do not recover renal function. Q J Med 1996;89:415-421.
-
(1996)
Q J Med
, vol.89
, pp. 415-421
-
-
Bhandari, S.1
Turney, J.H.2
-
51
-
-
0344979750
-
Haemodialysis-membrane biocompatibility and mortality of patients with dialysis-dependent acute renal failure: A prospective randomised multicentre trial
-
International Multicentre Study Group
-
Jorres A, Gahl GM, Dobis C, Polenakovic MH, Cakalaroski K, Rutkowski B, Kisielnicka E, Krieter DH, Rumpf KW, Guenther C, Gaus W, Hoegel J: Haemodialysis-membrane biocompatibility and mortality of patients with dialysis-dependent acute renal failure: A prospective randomised multicentre trial. International Multicentre Study Group. Lancet 1999; 354:1337-1341.
-
(1999)
Lancet
, vol.354
, pp. 1337-1341
-
-
Jorres, A.1
Gahl, G.M.2
Dobis, C.3
Polenakovic, M.H.4
Cakalaroski, K.5
Rutkowski, B.6
Kisielnicka, E.7
Krieter, D.H.8
Rumpf, K.W.9
Guenther, C.10
Gaus, W.11
Hoegel, J.12
-
52
-
-
0032821310
-
Outcome of critically ill patients treated with intermittent high-volume haemofiltration: A prospective cohort analysis
-
Oudemans-van Straaten HM, Bosman RJ, van der Spoel JI, Zandstra DF: Outcome of critically ill patients treated with intermittent high-volume haemofiltration: A prospective cohort analysis. Intens Care Med 1999;25:814-821.
-
(1999)
Intens Care Med
, vol.25
, pp. 814-821
-
-
Oudemans-Van Straaten, H.M.1
Bosman, R.J.2
Van Der Spoel, J.I.3
Zandstra, D.F.4
-
53
-
-
0032828335
-
Comparing continuous hemofiltration with hemodialysis in patients with severe acute renal failure
-
Swartz RD, Messana JM, Orzol S, Port FK: Comparing continuous hemofiltration with hemodialysis in patients with severe acute renal failure. Am J Kidney Dis 1999;34:424-432.
-
(1999)
Am J Kidney Dis
, vol.34
, pp. 424-432
-
-
Swartz, R.D.1
Messana, J.M.2
Orzol, S.3
Port, F.K.4
-
54
-
-
0026334347
-
Prognosis in septicemia complicated by acute renal failure requiring dialysis
-
Frost L, Pedersen RS, Hansen HE: Prognosis in septicemia complicated by acute renal failure requiring dialysis. Scand J Urol Nephrol 1991; 25:307-310.
-
(1991)
Scand J Urol Nephrol
, vol.25
, pp. 307-310
-
-
Frost, L.1
Pedersen, R.S.2
Hansen, H.E.3
-
55
-
-
0021252953
-
Meningococcal septicaemia treated with combined plasmapheresis and leucapheresis or with blood exchange
-
Bjorvatn B, Bjertnaes L, Fadnes HO, Flaegstad T, GuttebergTJ, Kristiansen B-E, Pape J, Rekvig OP, Østerud B, Aanderud L, Meningococcal septicaemia treated with combined plasmapheresis and leucapheresis or with blood exchange. Br Med J 1984;288:439-441.
-
(1984)
Br Med J
, vol.288
, pp. 439-441
-
-
Bjorvatn, B.1
Bjertnaes, L.2
Fadnes, H.O.3
Flaegstad, T.4
Gutteberg, T.J.5
Kristiansen, B.-E.6
Pape, J.7
Rekvig, O.P.8
Østerud, B.9
Aanderud, L.10
-
56
-
-
0022327638
-
Plasmapheresis in the treatment of severe meningococcal or pneumococcal septicaemia with DIC and fibrinolysis. Preliminary data on eight patients
-
Brandtzaeg P, Sirnes K, Folsland B, Godal HC, Kierulf P, Bruun JN, Dobloug J: Plasmapheresis in the treatment of severe meningococcal or pneumococcal septicaemia with DIC and fibrinolysis. Preliminary data on eight patients. Scand J Clin Lab Invest 1985;178(suppl):53-55.
-
(1985)
Scand J Clin Lab Invest
, vol.178
, Issue.SUPPL.
, pp. 53-55
-
-
Brandtzaeg, P.1
Sirnes, K.2
Folsland, B.3
Godal, H.C.4
Kierulf, P.5
Bruun, J.N.6
Dobloug, J.7
-
57
-
-
0003137735
-
Indications, application and appraisal of therapeutic plasma exchange in children
-
Bambauer R, Malchesky PS, Falkenhagen D (eds): Stuttgart, Schattauer
-
Graf N, Bambauer R, Limbach HG: Indications, application and appraisal of therapeutic plasma exchange in children: in Bambauer R, Malchesky PS, Falkenhagen D (eds): Therapeutic Plasma Exchange and Selective Plasma Separation. Stuttgart, Schattauer. 1987, pp 267-273.
-
(1987)
Therapeutic Plasma Exchange and Selective Plasma Separation
, pp. 267-273
-
-
Graf, N.1
Bambauer, R.2
Limbach, H.G.3
-
58
-
-
0002327649
-
Therapeutic plasma exchange in septic shock
-
Bambauer R, Malchesky PS, Falkenhagen D (eds): Stuttgart, Schattauer
-
Häuser W, Christmann F-J, Klein T, Traut G: Therapeutic plasma exchange in septic shock: in Bambauer R, Malchesky PS, Falkenhagen D (eds): Therapeutic Plasma Exchange and Selective Plasma Separation. Stuttgart, Schattauer, 1987, pp 287-293.
-
(1987)
Therapeutic Plasma Exchange and Selective Plasma Separation
, pp. 287-293
-
-
Häuser, W.1
Christmann, F.-J.2
Klein, T.3
Traut, G.4
-
59
-
-
0039507136
-
Reversal of advanced disseminated intravascular coagulation with uremia by plasma exchange
-
Bambauer R, Malchesky PS, Falkenhagen D (eds): International Symposium, Homburg/Saar, 1985. Stuttgart, Schattauer
-
Stegmayr BG, Wirell M: Reversal of advanced disseminated intravascular coagulation with uremia by plasma exchange; in Bambauer R, Malchesky PS, Falkenhagen D (eds): Therapeutic Plasma Exchange and Selective Plasma Separation. International Symposium, Homburg/Saar, 1985. Stuttgart, Schattauer, 1987, pp 133-136.
-
(1987)
Therapeutic Plasma Exchange and Selective Plasma Separation
, pp. 133-136
-
-
Stegmayr, B.G.1
Wirell, M.2
-
60
-
-
0024703683
-
Exchange blood transfusion and on-line plasma exchange for sepsis in infants
-
Asanuma Y, Takahashi T, Koyama K, Kato T, Omokawa S, Sueoka A, Tanaka J: Exchange blood transfusion and on-line plasma exchange for sepsis in infants. ASAIO Trans 1989;35: 343-345.
-
(1989)
ASAIO Trans
, vol.35
, pp. 343-345
-
-
Asanuma, Y.1
Takahashi, T.2
Koyama, K.3
Kato, T.4
Omokawa, S.5
Sueoka, A.6
Tanaka, J.7
-
61
-
-
0025690670
-
Plasma exchange in patients with severe consumption coagulopathy and acute renal failure
-
Stegmayr B, Bersecus O, Björsell-Östling E, Wirell M: Plasma exchange in patients with severe consumption coagulopathy and acute renal failure. Transfus Sci 1990;11:271-277.
-
(1990)
Transfus Sci
, vol.11
, pp. 271-277
-
-
Stegmayr, B.1
Bersecus, O.2
Björsell-Östling, E.3
Wirell, M.4
-
62
-
-
0024987774
-
Multiple organ failure: A role for plasma exchange?
-
McClelland P, Williams PS, Yaqooh M, Mostafa SM, Bone JM: Multiple organ failure: A role for plasma exchange? Intens Care Med 1990;16:100-103.
-
(1990)
Intens Care Med
, vol.16
, pp. 100-103
-
-
McClelland, P.1
Williams, P.S.2
Yaqooh, M.3
Mostafa, S.M.4
Bone, J.M.5
-
63
-
-
0026707782
-
Plasma and whole blood exchange in meningococcal sepsis
-
van Deuren M, Santman FW, van Dalen R, Sauerwein RW, Span LF, van der Meer JW: Plasma and whole blood exchange in meningococcal sepsis. Clin Infect Dis 1992;15:424-430.
-
(1992)
Clin Infect Dis
, vol.15
, pp. 424-430
-
-
Van Deuren, M.1
Santman, F.W.2
Van Dalen, R.3
Sauerwein, R.W.4
Span, L.F.5
Van Der Meer, J.W.6
-
64
-
-
0027724119
-
Plasmapheresis in the treatment of primary septic shock in humans
-
Gårdlund B, Sjoelin J, Nilsson A, Roll M, Wickerts CJ, Wikström B, Wretlind B: Plasmapheresis in the treatment of primary septic shock in humans. Scand J Infect Dis 1993;25: 757-761.
-
(1993)
Scand J Infect Dis
, vol.25
, pp. 757-761
-
-
Gårdlund, B.1
Sjoelin, J.2
Nilsson, A.3
Roll, M.4
Wickerts, C.J.5
Wikström, B.6
Wretlind, B.7
-
66
-
-
0001335038
-
Plasma exchange may improve survival of patients with multiorgan dysfunction syndrome including acute renal failure
-
Stegmayr BG, Norda R, Banga R, Rydvall A: Plasma exchange may improve survival of patients with multiorgan dysfunction syndrome including acute renal failure (abstract). Ther Apher 1999;3:141.
-
(1999)
Ther Apher
, vol.3
, pp. 141
-
-
Stegmayr, B.G.1
Norda, R.2
Banga, R.3
Rydvall, A.4
-
68
-
-
0030014812
-
Microspheres based detoxification system: A new method in convective blood purification
-
von Appen K, Weber C, Losert U, Schima H, Gurland HJ, Falkenhagen D: Microspheres based detoxification system: A new method in convective blood purification. Artif Organs 1996;20:420-425.
-
(1996)
Artif Organs
, vol.20
, pp. 420-425
-
-
Von Appen, K.1
Weber, C.2
Losert, U.3
Schima, H.4
Gurland, H.J.5
Falkenhagen, D.6
-
69
-
-
0028828423
-
Development of cationically modified cellulose adsorbents for the removal of endotoxins
-
Weber C, Henne B, Loth F, Schoenhofen M, Falkenhagen D: Development of cationically modified cellulose adsorbents for the removal of endotoxins. ASAIO J 1995;41:M430-M434.
-
(1995)
ASAIO J
, vol.41
-
-
Weber, C.1
Henne, B.2
Loth, F.3
Schoenhofen, M.4
Falkenhagen, D.5
-
70
-
-
0032810247
-
In vitro cell culture systems as the basis for an extracorporeal blood purification strategy in multiorgan failure treatment
-
Mitteregger R, White A, Weber C, Rossmanith E, Mohr T, Micksche M, Falkenhagen D: In vitro cell culture systems as the basis for an extracorporeal blood purification strategy in multiorgan failure treatment. Ther Apher 1999;3:257-263.
-
(1999)
Ther Apher
, vol.3
, pp. 257-263
-
-
Mitteregger, R.1
White, A.2
Weber, C.3
Rossmanith, E.4
Mohr, T.5
Micksche, M.6
Falkenhagen, D.7
-
71
-
-
0004952229
-
Push-pull sorbent-based pheresis (Biologic-DTPF system) in treatment of systemic inflammatory response syndrome (SIRS)
-
Ash SR, Levy H, Steezko J, Carr DJ, Blake DE: Push-pull sorbent-based pheresis (Biologic-DTPF system) in treatment of systemic inflammatory response syndrome (SIRS) (abstract). Ther Apher 1999;3:113.
-
(1999)
Ther Apher
, vol.3
, pp. 113
-
-
Ash, S.R.1
Levy, H.2
Steezko, J.3
Carr, D.J.4
Blake, D.E.5
|